Richard A Preston

Professor of Clinical

  • 3412 Citations
1978 …2019

Research output per year

If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Richard A Preston is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 7 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output

Outcomes of minority patients with very severe hypertension (>220/>120 mmHg)

Preston, R. A., Arciniegas, R., DeGraff, S., Materson, B. J., Bernstein, J. & Afshartous, D., Feb 1 2019, In : Journal of Hypertension. 37, 2, p. 415-425 11 p.

Research output: Contribution to journalArticle

  • 2 Scopus citations

    Pharmacokinetics, safety, and tolerability of intravenous durlobactam and sulbactam in subjects with renal impairment and healthy matched control subjects

    O'Donnell, J., Preston, R. A., Mamikonyan, G., Stone, E. & Isaacs, R., Jan 1 2019, In : Antimicrobial agents and chemotherapy. 63, 9, e00794-19.

    Research output: Contribution to journalArticle

    Open Access
  • 1 Scopus citations

    Single-Center Evaluation of the Pharmacokinetics of WCK 5222 (Cefepime-Zidebactam Combination) in Subjects with Renal Impairment

    Preston, R. A., Mamikonyan, G., DeGraff, S., Chiou, J., Kemper, C. J., Xu, A., Mastim, M., Yeole, R., Chavan, R., Patel, A., Friedland, H. D. & Bhatia, A., Jan 1 2019, In : Antimicrobial Agents and Chemotherapy. 63, 1

    Research output: Contribution to journalArticle

  • 3 Scopus citations

    Single-center investigation of the pharmacokinetics of WCK 4282 (cefepime-tazobactam combination) in renal impairment

    Preston, R. A., Mamikonyan, G., Mastim, M., Garg, D., Kemper, C. J., Xu, A., Yeole, R., Chavan, R., Friedland, H. D. & Bhatia, A., Jan 1 2019, In : Antimicrobial agents and chemotherapy. 63, 10, e00873-19.

    Research output: Contribution to journalArticle

  • Effects of Renal Impairment and Hemodialysis on the Pharmacokinetics and Safety of the Glecaprevir and Pibrentasvir Combination in Hepatitis C Virus-Negative Subjects

    Kosloski, M. P., Zhao, W., Marbury, T. C., Preston, R. A., Collins, M. G., Pugatch, D., Mensa, F., Kort, J. & Liu, W., Mar 1 2018, In : Antimicrobial Agents and Chemotherapy. 62, 3, e01990-17.

    Research output: Contribution to journalArticle

  • 8 Scopus citations